Research Catalogue | Pure Peptides Australia https://pure-peptidesaus.com/shop/ Mon, 12 Oct 2026 09:39:36 +0000 en-US hourly 1 https://wordpress.org/?v=7.0.7 https://pure-peptidesaus.com/wp-content/uploads/2026/05/cropped-Logo-Pure-Peptides-Aus-32x32.png Research Catalogue | Pure Peptides Australia https://pure-peptidesaus.com/shop/ 32 32 Tirzepatide (20mg) https://pure-peptidesaus.com/product/tirzepatide-20mg/ https://pure-peptidesaus.com/product/tirzepatide-20mg/#respond Mon, 12 Oct 2026 06:02:35 +0000 https://pure-peptidesaus.com/?post_type=product&p=723 Tirzepatide 20mg, a dual GIP/GLP-1 receptor agonist studied in incretin signalling and comparative receptor pharmacology. Separate 20mg catalogue quantity.

The post Tirzepatide (20mg) appeared first on Pure Peptides Australia.

]]> Tirzepatide, identified during development as LY3298176, is a peptide with agonist activity at glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its scientific background includes discovery research and experiments comparing receptor responses. This 20mg listing provides the correctly spelled compound name and a distinct catalogue quantity.

Mechanism & Research Background

The dual-receptor profile makes tirzepatide different from a GLP-1-only analogue and from a triple agonist that also targets the glucagon receptor. Published pharmacology has examined how tirzepatide engages GIP and GLP-1 receptors, including differences in signalling behaviour at each target. The relative response depends on the receptor system and assay conditions rather than on the name alone.

Areas of Research

  • GIP and GLP-1 receptor activation and comparative pharmacology.
  • Differences between receptor binding and downstream signalling measurements.
  • Dual- versus single-receptor activity in defined research models.

The 20mg entry provides a larger listed quantity than the separate 10mg product, without implying a different mechanism or greater efficacy. Quantitative experiments depend on documented material content and preparation conditions. Findings from pharmaceutical studies should not be treated as proof that a supplier’s research batch matches a finished medicine.

Product Details

  • Product: Tirzepatide 20mg
  • Listed quantity: 20mg
  • Compound class: Dual GIP and GLP-1 receptor agonist peptide
  • Product code: TR20

Storage & Handling

Follow the storage conditions and handling guidance in the applicable supplier documentation. Protect the material from unsuitable heat, light and moisture, and record the batch used in each experiment. Preparation and storage requirements depend on the supplied formulation and the research method.

Batch Documentation

Certificates of analysis should be matched to the product and batch. Consult the relevant report for measured identity, content and purity; a purity result alone does not establish sterility or endotoxin status.

Research References

Important Notice

Premium research peptides synthesised and shipped from Australia. For in-vitro research purposes only. Strictly not for human or veterinary consumption. All products supplied are strictly for laboratory research and development. This information describes the compound’s research background and does not provide dosing instructions or claim a therapeutic benefit.

The post Tirzepatide (20mg) appeared first on Pure Peptides Australia.

]]> https://pure-peptidesaus.com/product/tirzepatide-20mg/feed/ 0 Tirzepatide (10mg) https://pure-peptidesaus.com/product/tirzepatide-10mg/ https://pure-peptidesaus.com/product/tirzepatide-10mg/#respond Mon, 12 Oct 2026 06:02:25 +0000 https://pure-peptidesaus.com/?post_type=product&p=722 Tirzepatide 10mg, a dual GIP/GLP-1 receptor agonist studied in incretin signalling and comparative receptor pharmacology.

The post Tirzepatide (10mg) appeared first on Pure Peptides Australia.

]]> Tirzepatide, identified during development as LY3298176, is a peptide with agonist activity at glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its scientific background includes discovery research and experiments comparing receptor responses. This 10mg listing provides the correctly spelled compound name and a distinct catalogue quantity.

Mechanism & Research Background

The dual-receptor profile makes tirzepatide different from a GLP-1-only analogue and from a triple agonist that also targets the glucagon receptor. Published pharmacology has examined how tirzepatide engages GIP and GLP-1 receptors, including differences in signalling behaviour at each target. The relative response depends on the receptor system and assay conditions rather than on the name alone.

Areas of Research

  • GIP and GLP-1 receptor activation and comparative pharmacology.
  • Differences between receptor binding and downstream signalling measurements.
  • Dual- versus single-receptor activity in defined research models.

The 10mg amount identifies the listed product quantity; it is not a solution concentration or an administration schedule. A research comparison should document the compound identity, assay method and actual material tested. Studies of finished medicines do not verify the identity, purity or clinical suitability of this catalogue product.

Product Details

  • Product: Tirzepatide 10mg
  • Listed quantity: 10mg
  • Compound class: Dual GIP and GLP-1 receptor agonist peptide
  • Product code: TR10

Storage & Handling

Follow the storage conditions and handling guidance in the applicable supplier documentation. Protect the material from unsuitable heat, light and moisture, and record the batch used in each experiment. Preparation and storage requirements depend on the supplied formulation and the research method.

Batch Documentation

Certificates of analysis should be matched to the product and batch. Consult the relevant report for measured identity, content and purity; a purity result alone does not establish sterility or endotoxin status.

Research References

Important Notice

Premium research peptides synthesised and shipped from Australia. For in-vitro research purposes only. Strictly not for human or veterinary consumption. All products supplied are strictly for laboratory research and development. This information describes the compound’s research background and does not provide dosing instructions or claim a therapeutic benefit.

The post Tirzepatide (10mg) appeared first on Pure Peptides Australia.

]]> https://pure-peptidesaus.com/product/tirzepatide-10mg/feed/ 0 Tesamorelin (20mg) https://pure-peptidesaus.com/product/tesamorelin-20mg/ https://pure-peptidesaus.com/product/tesamorelin-20mg/#respond Mon, 12 Oct 2026 06:02:14 +0000 https://pure-peptidesaus.com/?post_type=product&p=721 Tesamorelin 20mg, a stabilised GHRH analogue studied in growth hormone-axis and metabolic research. Larger listed quantity within the same compound range.

The post Tesamorelin (20mg) appeared first on Pure Peptides Australia.

]]> Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), investigated in endocrine and metabolic research. Its structure is based on the GHRH(1–44) sequence with an N-terminal modification designed to increase stability. This 20mg listing identifies a separate catalogue quantity within the tesamorelin range.

Mechanism & Research Background

Tesamorelin acts at the GHRH receptor, upstream of growth hormone release, rather than directly replacing growth hormone. Published studies have examined growth hormone-axis activity alongside measurements of visceral adipose tissue and liver fat in defined clinical populations. Those findings provide research context; they do not establish general fat-loss benefits or equivalence between a research catalogue material and the formulations used in those trials.

Areas of Research

  • GHRH receptor activity and growth hormone-axis responses.
  • Relationships between endocrine measurements and metabolic endpoints.
  • Comparative study of stabilised GHRH analogues.

The 20mg entry contains a different listed quantity from the 10mg entry, rather than a different receptor mechanism. Comparisons should use the actual analytical content and study concentration, not assume a different biological effect from the pack label. Clinical findings remain specific to the formulations and populations investigated.

Product Details

  • Product: Tesamorelin 20mg
  • Listed quantity: 20mg
  • Compound class: Growth hormone-releasing hormone analogue
  • Product code: TSM20

Storage & Handling

Follow the storage conditions and handling guidance in the applicable supplier documentation. Protect the material from unsuitable heat, light and moisture, and record the batch used in each experiment. Preparation and storage requirements depend on the supplied formulation and the research method.

Batch Documentation

Certificates of analysis should be matched to the product and batch. Consult the relevant report for measured identity, content and purity; a purity result alone does not establish sterility or endotoxin status.

Research References

Important Notice

Premium research peptides synthesised and shipped from Australia. For in-vitro research purposes only. Strictly not for human or veterinary consumption. All products supplied are strictly for laboratory research and development. This information describes the compound’s research background and does not provide dosing instructions or claim a therapeutic benefit.

The post Tesamorelin (20mg) appeared first on Pure Peptides Australia.

]]> https://pure-peptidesaus.com/product/tesamorelin-20mg/feed/ 0 Tesamorelin (10mg) https://pure-peptidesaus.com/product/tesamorelin-10mg/ https://pure-peptidesaus.com/product/tesamorelin-10mg/#respond Mon, 12 Oct 2026 06:02:03 +0000 https://pure-peptidesaus.com/?post_type=product&p=720 Tesamorelin 10mg, a stabilised GHRH analogue studied in growth hormone-axis and metabolic research. Separate 10mg catalogue quantity.

The post Tesamorelin (10mg) appeared first on Pure Peptides Australia.

]]> Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), investigated in endocrine and metabolic research. Its structure is based on the GHRH(1–44) sequence with an N-terminal modification designed to increase stability. This 10mg listing identifies a separate catalogue quantity within the tesamorelin range.

Mechanism & Research Background

Tesamorelin acts at the GHRH receptor, upstream of growth hormone release, rather than directly replacing growth hormone. Published studies have examined growth hormone-axis activity alongside measurements of visceral adipose tissue and liver fat in defined clinical populations. Those findings provide research context; they do not establish general fat-loss benefits or equivalence between a research catalogue material and the formulations used in those trials.

Areas of Research

  • GHRH receptor activity and growth hormone-axis responses.
  • Relationships between endocrine measurements and metabolic endpoints.
  • Comparative study of stabilised GHRH analogues.

The 10mg entry can be distinguished from the 20mg listing by its stated quantity and product code. This pack-size distinction does not change the compound’s receptor target. Published clinical studies used defined populations and formulations; that context should remain attached to any discussion of their results.

Product Details

  • Product: Tesamorelin 10mg
  • Listed quantity: 10mg
  • Compound class: Growth hormone-releasing hormone analogue
  • Product code: TSM10

Storage & Handling

Follow the storage conditions and handling guidance in the applicable supplier documentation. Protect the material from unsuitable heat, light and moisture, and record the batch used in each experiment. Preparation and storage requirements depend on the supplied formulation and the research method.

Batch Documentation

Certificates of analysis should be matched to the product and batch. Consult the relevant report for measured identity, content and purity; a purity result alone does not establish sterility or endotoxin status.

Research References

Important Notice

Premium research peptides synthesised and shipped from Australia. For in-vitro research purposes only. Strictly not for human or veterinary consumption. All products supplied are strictly for laboratory research and development. This information describes the compound’s research background and does not provide dosing instructions or claim a therapeutic benefit.

The post Tesamorelin (10mg) appeared first on Pure Peptides Australia.

]]> https://pure-peptidesaus.com/product/tesamorelin-10mg/feed/ 0 Semaglutide (10mg) https://pure-peptidesaus.com/product/semaglutide-10mg/ https://pure-peptidesaus.com/product/semaglutide-10mg/#respond Mon, 12 Oct 2026 06:01:54 +0000 https://pure-peptidesaus.com/?post_type=product&p=719 Semaglutide 10mg, a modified GLP-1 analogue for research into receptor activity, peptide stability and comparative metabolic signalling.

The post Semaglutide (10mg) appeared first on Pure Peptides Australia.

]]> Semaglutide is a modified glucagon-like peptide-1 (GLP-1) analogue investigated through its activity at the GLP-1 receptor. The discovery programme examined how peptide modifications influence receptor activity, enzymatic stability and albumin interaction. This 10mg catalogue entry provides a research reference for the compound rather than describing a finished pharmaceutical formulation.

Mechanism & Research Background

Semaglutide’s structure includes modifications designed to resist enzymatic degradation and support albumin binding. These features form part of its published pharmacological profile. In receptor-focused research, semaglutide can be distinguished from tirzepatide, which has a dual GIP/GLP-1 profile, and retatrutide, which also targets the glucagon receptor.

Areas of Research

  • GLP-1 receptor activity and peptide structure–activity relationships.
  • Albumin interaction and stability-related peptide modifications.
  • Comparative single- and multi-receptor signalling studies.

An assay using a research material is different from a study of a specific medicine or delivery system. Published findings do not establish that this catalogue product is equivalent to a branded medicine, and the supplied strength does not indicate a dosing schedule. Researchers should distinguish compound mass from solution concentration and record the material’s exact identity and analytical basis.

Product Details

  • Product: Semaglutide 10mg
  • Listed quantity: 10mg
  • Compound class: GLP-1 receptor agonist peptide
  • Product code: SM10

Storage & Handling

Follow the storage conditions and handling guidance in the applicable supplier documentation. Protect the material from unsuitable heat, light and moisture, and record the batch used in each experiment. Preparation and storage requirements depend on the supplied formulation and the research method.

Batch Documentation

Certificates of analysis should be matched to the product and batch. Consult the relevant report for measured identity, content and purity; a purity result alone does not establish sterility or endotoxin status.

Research References

Important Notice

Premium research peptides synthesised and shipped from Australia. For in-vitro research purposes only. Strictly not for human or veterinary consumption. All products supplied are strictly for laboratory research and development. This information describes the compound’s research background and does not provide dosing instructions or claim a therapeutic benefit.

The post Semaglutide (10mg) appeared first on Pure Peptides Australia.

]]> https://pure-peptidesaus.com/product/semaglutide-10mg/feed/ 0 Retatrutide (20mg) https://pure-peptidesaus.com/product/retatrutide-20mg/ https://pure-peptidesaus.com/product/retatrutide-20mg/#respond Mon, 12 Oct 2026 06:01:36 +0000 https://pure-peptidesaus.com/?post_type=product&p=718 Retatrutide 20mg, a triple GIP, GLP-1 and glucagon receptor agonist investigated in multi-receptor pharmacology and metabolic signalling research.

The post Retatrutide (20mg) appeared first on Pure Peptides Australia.

]]> Retatrutide, identified in early research as LY3437943, is a peptide studied for activity at three receptor systems: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon receptors. Its research profile connects multi-receptor pharmacology with metabolic signalling. This 20mg listing is a separate catalogue quantity from the existing lower-strength entries.

Mechanism & Research Background

The compound’s triple-agonist design allows researchers to examine interactions with three related but distinct hormone receptors. Discovery studies and structural research have investigated receptor activation and binding interactions. This differs from the single GLP-1 receptor emphasis of semaglutide and the dual GIP/GLP-1 profile of tirzepatide.

Areas of Research

  • Comparative activation of GIP, GLP-1 and glucagon receptors.
  • Structural interactions between peptide ligands and their target receptors.
  • Multi-receptor signalling within defined metabolic research models.

Comparisons between single-, dual- and triple-receptor compounds require matched assay conditions and suitable controls. Published results depend on the material, model and endpoints used; they are not a prediction of weight loss or other outcomes from this catalogue product. The 20mg label describes the listed quantity, not a prepared solution concentration or an administration instruction.

Product Details

  • Product: Retatrutide 20mg
  • Listed quantity: 20mg
  • Compound class: GIP, GLP-1 and glucagon receptor agonist peptide
  • Product code: RT20

Storage & Handling

Follow the storage conditions and handling guidance in the applicable supplier documentation. Protect the material from unsuitable heat, light and moisture, and record the batch used in each experiment. Preparation and storage requirements depend on the supplied formulation and the research method.

Batch Documentation

Certificates of analysis should be matched to the product and batch. Consult the relevant report for measured identity, content and purity; a purity result alone does not establish sterility or endotoxin status.

Research References

Important Notice

Premium research peptides synthesised and shipped from Australia. For in-vitro research purposes only. Strictly not for human or veterinary consumption. All products supplied are strictly for laboratory research and development. This information describes the compound’s research background and does not provide dosing instructions or claim a therapeutic benefit.

The post Retatrutide (20mg) appeared first on Pure Peptides Australia.

]]> https://pure-peptidesaus.com/product/retatrutide-20mg/feed/ 0 PT141 (10mg) https://pure-peptidesaus.com/product/pt141-10mg/ https://pure-peptidesaus.com/product/pt141-10mg/#respond Mon, 12 Oct 2026 06:01:27 +0000 https://pure-peptidesaus.com/?post_type=product&p=717 PT141 10mg, also known as bremelanotide, for research into melanocortin receptor activity and related signalling pathways.

The post PT141 (10mg) appeared first on Pure Peptides Australia.

]]> PT-141, also known as bremelanotide, is a synthetic peptide analogue associated with melanocortin-receptor research. The compound has been investigated in studies of receptor activity and neurobehavioural signalling. This 10mg entry identifies the research material without making a sexual-performance or treatment claim.

Mechanism & Research Background

Published research describes PT-141 as an agonist at melanocortin receptors, including MC3R and MC4R. Its scientific context therefore concerns melanocortin pathways rather than the phosphodiesterase-5 pathway associated with some other compounds studied in sexual-response research. Receptor activity, exposure and behavioural endpoints are separate measurements and should not be treated as interchangeable evidence.

Areas of Research

  • Melanocortin receptor activation and comparative receptor pharmacology.
  • Relationships between receptor signalling and experimental neurobehavioural endpoints.
  • Compound identity and exposure-response measurements in defined study models.

Studies involving a pharmaceutical formulation of bremelanotide do not validate a supplier’s research batch or show equivalence to that formulation. The precise chemical identity, salt form and analytical results need to match the material under investigation. A catalogue strength is also different from an assay concentration.

Product Details

  • Product: PT141 10mg
  • Listed quantity: 10mg
  • Compound class: Melanocortin receptor agonist peptide
  • Product code: P41

Storage & Handling

Follow the storage conditions and handling guidance in the applicable supplier documentation. Protect the material from unsuitable heat, light and moisture, and record the batch used in each experiment. Preparation and storage requirements depend on the supplied formulation and the research method.

Batch Documentation

Certificates of analysis should be matched to the product and batch. Consult the relevant report for measured identity, content and purity; a purity result alone does not establish sterility or endotoxin status.

Research References

Important Notice

Premium research peptides synthesised and shipped from Australia. For in-vitro research purposes only. Strictly not for human or veterinary consumption. All products supplied are strictly for laboratory research and development. This information describes the compound’s research background and does not provide dosing instructions or claim a therapeutic benefit.

The post PT141 (10mg) appeared first on Pure Peptides Australia.

]]> https://pure-peptidesaus.com/product/pt141-10mg/feed/ 0 NAD+ (1000mg) https://pure-peptidesaus.com/product/nad-plus-1000mg/ https://pure-peptidesaus.com/product/nad-plus-1000mg/#respond Mon, 12 Oct 2026 06:01:17 +0000 https://pure-peptidesaus.com/?post_type=product&p=716 NAD+ 1000mg, an oxidised coenzyme for biochemical research into redox reactions, NAD turnover and NAD-dependent enzyme activity. NAD+ is not a peptide.

The post NAD+ (1000mg) appeared first on Pure Peptides Australia.

]]> NAD+ is the oxidised form of nicotinamide adenine dinucleotide, a coenzyme involved in cellular redox chemistry and metabolism. Although included in peptide catalogues, NAD+ is not a peptide. It is relevant to biochemical research examining how cells transfer electrons, maintain NAD pools and support reactions carried out by NAD-dependent enzymes.

Mechanism & Research Background

NAD+ and its reduced partner NADH participate in redox reactions. NAD+ also serves as a substrate for enzyme families such as sirtuins and poly(ADP-ribose) polymerases. Experimental work has measured NAD synthesis and consumption in cell lines, and has examined the relationship between extracellular NAD+ and cellular DNA-repair responses. These research themes do not demonstrate a consumer energy, cognition or longevity benefit from this product.

Areas of Research

  • NAD+/NADH-associated redox measurements and enzyme assays.
  • NAD synthesis, turnover and consumption in cultured cells.
  • NAD-dependent signalling and DNA-repair pathways.

The chemical form matters when designing an assay: NAD+, NADH and precursors such as nicotinamide riboside are different materials. Researchers should check the supplier’s salt or hydrate designation, assay basis and any documented buffer compatibility before interpreting mass-based measurements. No specific salt form is inferred from the 1000mg product name.

Product Details

  • Product: NAD+ 1000mg
  • Listed quantity: 1000mg
  • Compound class: Oxidised nicotinamide adenine dinucleotide coenzyme
  • Product code: NJ1000

Storage & Handling

Follow the storage conditions and handling guidance in the applicable supplier documentation. Protect the material from unsuitable heat, light and moisture, and record the batch used in each experiment. Preparation and storage requirements depend on the supplied formulation and the research method.

Batch Documentation

Certificates of analysis should be matched to the product and batch. Consult the relevant report for measured identity, content and purity; a purity result alone does not establish sterility or endotoxin status.

Research References

Important Notice

Premium research compound synthesised and shipped from Australia. For in-vitro research purposes only. Strictly not for human or veterinary consumption. All products supplied are strictly for laboratory research and development. This information describes the compound’s research background and does not provide dosing instructions or claim a therapeutic benefit.

The post NAD+ (1000mg) appeared first on Pure Peptides Australia.

]]> https://pure-peptidesaus.com/product/nad-plus-1000mg/feed/ 0 HGH (36IU) https://pure-peptidesaus.com/product/hgh-36iu/ https://pure-peptidesaus.com/product/hgh-36iu/#respond Mon, 12 Oct 2026 06:01:07 +0000 https://pure-peptidesaus.com/?post_type=product&p=715 HGH 36IU catalogue entry for growth hormone-receptor and protein-hormone research. IU denotes biological activity; formulation and potency details are batch-specific.

The post HGH (36IU) appeared first on Pure Peptides Australia.

]]> Human growth hormone (HGH) is a protein hormone associated with growth hormone-receptor signalling and endocrine regulation. It differs from GHRH analogues such as CJC-1295 and tesamorelin: HGH is the hormone investigated at the growth hormone receptor, whereas those analogues act on pathways involved in hormone release. This listing is identified by the supplied catalogue as HGH 36IU.

Mechanism & Research Background

Growth hormone signalling involves receptor-associated intracellular pathways, including JAK2 and STAT transcription factors. Laboratory studies have examined how these signals affect gene expression and how responses vary with exposure patterns. This receptor-level research is distinct from demonstrating the identity, potency or suitability of any particular supplied preparation.

Areas of Research

  • Growth hormone-receptor signalling and downstream transcription-factor responses.
  • Comparisons between direct hormone exposure and upstream secretagogue pathways.
  • Assay design for protein-hormone identity, activity and stability.

International Units describe biological activity, rather than a concentration or a volume. The listed 36IU should therefore not be interpreted as an injection amount or converted to a mass without an applicable reference standard. The supplier documentation should identify the protein preparation, whether it is recombinant, the formulation and the basis of its activity measurement.

Product Details

  • Product: HGH 36IU
  • Listed quantity: 36IU listed biological activity
  • Compound class: Human growth hormone protein
  • Product code: H36

Storage & Handling

Follow the storage conditions and handling guidance in the applicable supplier documentation. Protect the material from unsuitable heat, light and moisture, and record the batch used in each experiment. Preparation and storage requirements depend on the supplied formulation and the research method.

Batch Documentation

Certificates of analysis should be matched to the product and batch. Consult the relevant report for measured identity, content and purity; a purity result alone does not establish sterility or endotoxin status.

Research References

Important Notice

Premium research peptides synthesised and shipped from Australia. For in-vitro research purposes only. Strictly not for human or veterinary consumption. All products supplied are strictly for laboratory research and development. This information describes the compound’s research background and does not provide dosing instructions or claim a therapeutic benefit.

The post HGH (36IU) appeared first on Pure Peptides Australia.

]]> https://pure-peptidesaus.com/product/hgh-36iu/feed/ 0 Epitalon (10mg) https://pure-peptidesaus.com/product/epitalon-10mg/ https://pure-peptidesaus.com/product/epitalon-10mg/#respond Mon, 12 Oct 2026 06:00:37 +0000 https://pure-peptidesaus.com/?post_type=product&p=714 Epitalon 10mg, a synthetic Ala–Glu–Asp–Gly tetrapeptide investigated in cell-culture studies of telomerase, telomere maintenance and gene regulation.

The post Epitalon (10mg) appeared first on Pure Peptides Australia.

]]> Epitalon, also written as Epithalon in the scientific literature, is a synthetic tetrapeptide with the amino-acid sequence Ala–Glu–Asp–Gly. Its research background includes experiments on telomerase activity, telomere maintenance and gene regulation in cultured cells. This 10mg listing provides the compound identity and research context without presenting it as an established anti-ageing treatment.

Mechanism & Research Background

Telomeres are structures at chromosome ends, while telomerase is an enzyme involved in maintaining telomeric DNA. Published cell-culture experiments have examined whether Epitalon changes telomerase-related activity or telomere length. More recent work has compared responses across different cell lines. These are experimental observations in particular models, rather than evidence that this product extends human lifespan or produces rejuvenation.

Areas of Research

  • Telomerase activity and telomere-length measurements in cell culture.
  • Gene-expression responses to short peptides.
  • Differences between cell types, assay methods and experimental exposure conditions.

Cellular ageing research requires more than a single telomere measurement. Cell viability, growth behaviour, appropriate controls and the exact study model all affect how an observation should be interpreted. Epitalon should also be distinguished from Epithalamin, which is a different preparation.

Product Details

  • Product: Epitalon 10mg
  • Listed quantity: 10mg
  • Compound class: Synthetic tetrapeptide
  • Product code: ET10

Storage & Handling

Follow the storage conditions and handling guidance in the applicable supplier documentation. Protect the material from unsuitable heat, light and moisture, and record the batch used in each experiment. Preparation and storage requirements depend on the supplied formulation and the research method.

Batch Documentation

Certificates of analysis should be matched to the product and batch. Consult the relevant report for measured identity, content and purity; a purity result alone does not establish sterility or endotoxin status.

Research References

Important Notice

Premium research peptides synthesised and shipped from Australia. For in-vitro research purposes only. Strictly not for human or veterinary consumption. All products supplied are strictly for laboratory research and development. This information describes the compound’s research background and does not provide dosing instructions or claim a therapeutic benefit.

The post Epitalon (10mg) appeared first on Pure Peptides Australia.

]]> https://pure-peptidesaus.com/product/epitalon-10mg/feed/ 0